Geisinger Medical Laboratories Research & Publications

Peer-Reviewed Publications:

  1. Liu H, Shi J, Lin F. The potential diagnostic utility of TROP-2 in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2017;25(8):525-533.

  2. Ahmad M, Jacobs D, Wu H, Wolk DM, Kazmi, SAJ, Jaramillo C, Toms SA. Cladophialophora bantiana: A rare intracerebral fungal abscess. Case series and review of literature. Surg J. 2017;2(3):e62-e68.

  3. Murphy M, Ferringer T, Elston . Educational Gaps in Molecular Diagnostics, Genomics, and Personalized Medicine in Dermatopathology Training: A Survey of US Dermatopathology Fellowship Program Directors. ADJP. 2017;Accepted:-.

  4. Tjarks BJ, Ferringer TC. Red-blue nodule on the scalp. Cutis. 2017;99(1):25-26.

  5. Kandukuri S, Lin F, Liu H. Application of IHC on FNA and small tissue biopsy specimens. Arch Pathol Lab Med. 2017;In:Press.

  6. Wang HL, Lin F. Application of IHC on GI, liver, pancreas and biliary tract. Arch Pathol Lab Med. 2017;In :preparation.

  7. Lin F, Shi J, Ma X, et al. Detection of albumin expression by RNA in situ hybridization in hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Am J Clin Pathol. 2017;In :preparation.

  8. Liu H, Shi J, Ma X, Lin F, et al. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of GCDFP15 in breast carcinomas. Am J Clin Pathol. 2017;In :preparation.

  9. Shahab A, Liu H, Lin F. . Uroplakin II is a Useful Immunomarker for Identification of Urothelial Carcinomas. Am J Clin Pathol. 2017;In :preparation.

  10. Kandukuri S, Liu H, Lin F. The diagnostic utility of CK7, maspin and MUC5AC in distinguishing gastric-foveolar type mucinous neoplasm of the pancreas from gastric contaminants on fine needle aspiration specimens. Am J Clin Pathol. 2017;In :preparation.

  11. Luo X, Keller MA, James I, Liu S, Grant ML, Iftikhar A, Dobey TX, Czulewicz, Nance SJ, Li Y. Strategies to identify candidates for D variant genotyping. Blood Transfus. 2017;Apr 5:1-9.

  12. Qiu J, Bhattacharyya S, Grant M, Bains A. Diffuse Large B-Cell Lymphoma Trans-differentiating into CD30 Positive Anaplastic Large Cell-like Lymphoma. Ann Hematol Oncol. 2017;4(7):1162-1167.

  13. Wang HL, Kim CJ, Koo J, Zhou W, Choi EK, Arcega R, Chen ZE, Wang H, Zhang L, Lin F. Practical immunohistochemistry in neoplastic pathology of the gastrointestinal tract, liver, biliary tract, and pancreas. Arch Pathol Lab Med. 2017;141:155-1180.

  14. Grant ML, Parajuli S, Deleon-Gonsalves R, Potula R, Truant AL. Evaluation of the Becton Dickinson Phoenix Yeast Panel and RapID Yeast Plus System in the Identification of Yeast and Yeast Like Organisms. Can J Infect Dis Med Microbiol.. 2016;2016:4094932.

  15. Grant ML, Karp JK, Palladino M, Le N, Hall N, Herman JH. Does Therapeutic Plasma Exchange Have a Role in the Treatment of Prosthetic Hip Associated Cobalt Toxicity. Transfusion. 2016;56(9):2368-73.

  16. Lo SY, Huq Saifee NP, Mason OB, Greene DN. Filling in the gaps with non-standard body fluids. Practical Laboratory Medicine. 2016;5:24-31.

  17. Lo SY, Gordon C, Sadilkova K, Jack RM, Dickerson JA. Quantifying MMA by SLE LC-MS/MS: Unexpected challenges in assay development. Clin Biochem. 2016;49(13-14):967-972..

  18. Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi AH, Duits LC, Bergman JJ, Rustgi A, Falk GW. . A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev. 2016;26(2):240-248.

  19. Shi J, Liu H, Ma XJ, Chen Z, He MX, Luo Y, Lin F. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Arch Pathol Lab Med. 2016;140(4):332-349.

  20. Kim CJ, Baruch-Oren T, Lin F, Fan XS, Yang XJ, Wang HL. Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas. J Clin Pathol. 2016;69(12):1046-1050.

  21. Green A, Ferringer T. Cyst on the eyebrow. Cutis. 2016;97(4):272, 277-278.

  22. Nicolli EA, Ghosh A, Haft S, Frank R, Saunders J, Cohen N, Mirza N. IL-1 Receptor Antagonist Inhibits Early Granulation Formation. Ann Otol Rhinol Laryngol. 2016;125(4):284-289.

  23. Stoneking LR, Winkler JP, DeLuca LA, Stolz U, Stutz A, Luman JC, Gaub M, Wolk DM, Fiorello AB, Denninghoff KR. Physician documentation of sepsis syndrome is associated with more aggressive treatment. West J Emerg Med. 2016;16(3):401-407.

  24. Pfaller, MA, Wolk, DM, Lowery, TJ. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2016;11:103-117.

  25. Hernandez DR, Newton DW, Ledeboer NA, Buchan B, Young C, Clark AE, Connoly J, Wolk DM. Multicenter Evaluation of MRSASelect II Chromogenic Agar for Identification of Methicillin-Resistant Staphylococcus aureus from Wound and Nasal Specimens. J Clin Microbiol. 2016;54(2):305-311.

  26. Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish N, Saubolle M, Weissfeld A, Weinstein, M, Liebow EB, and Wolk DM. Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis. Clin Microbiol Rev. 2016;29(1):59-103.

  27. Frank R, Lal P, Kearns J, Molina MR, Wald JW, Goldberg LR, Kamoun M. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens. Am J Clin Pathol. 2016;145(1):62-68.

  28. Pineda JJ, Diehl DL, Miao CL, Johal AJ, Khara HS, Bhanushali A and Chen Z. EUS-guided liver biopsy provides diagnostic samples comparable with those via the percutaneous or transjugular route. Gastrointest Endosc. 2016;88:360-365.

  29. Biju J, Kip NS. Molecular testing and automated data management enhances efficiency of laboratory workflow and reduces healthcare expenditure. MLO. 2016;February:2016.

  30. Critchley-Thorne R., Prichard J, Diehl D, Li J, et al. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev. 2016;25(6):956-968.

  31. Cooper JD, Tyler WB, Jaramillo Hoyos CM, Atienza Medina R. Prototheca wickerhamii in a Patient With Chronic Hepatitis C. Infect Dis Clin Pract. 2016;24(5):283-285.

  32. Graham J, Hossler E. Lichen striatus. Cutis. 2016;97(2):86, 120, 122.

  33. Schleich C, Ferringer T. Desmoplastic melanoma. Cutis. 2015;96(5):306, 213, 314, 335.

  34. Ferringer T. Leading innovation (editorial) . Cutis. 2015;96(4):213-214.

  35. Spiker A, Ferringer T. Dermatopathology diagnosis: chromoblastomycosis. Cutis. 2015;96(4):224, 267-268.

  36. De Moll EH, Fu Y, Wieder S, Harcharik S, Yao J, Ferringer T, Chang R, Gnjatic S, Remark R, Chipuk J, Birge MB, Phelps RG, Saenger YM. Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanoma. Cancer Immunol Immunother. 2015;64(9):1193-1203.

  37. Ferringer T, Zaleski M. Extramammary Paget disease. Cutis. 2015;95(6):308, 315-316.

  38. Egnatios GL, Ferringer T. Clinical follow up of atypical Spitz tumors analyzed by FISH. Am J Dermatopathol. 2015;38(4):289-296.

  39. Prickett KA, Ferringer TC. What's eating you? Cutaneous larva migrans. Cutis. 2015;95(3):126-128.

  40. Hall LD, Bodendorf MO, Najarian DJ, Ferringer T, Elston D. Soluble adenylyl cyclase (sAC) immunostaining distinguishes pseudomelanocytic nests in lichenoid tissue reaction. J Cutan Pathol. 2015;42(3):232-235.

  41. Boddicker RL, Kip NS, Xing X,et al. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-?B positive feedback loop in peripheral T-cell lymphoma. Blood. 2015;125(20):3118-3127.

  42. Lin G, Doyle LA. An update on the application of newly described immunohistochemical markers in soft tissue pathology. Arch Pathol Lab Med. 2015;139(1):106-121.

  43. Novak DJ, Bai Y, Cooke RK. Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. Transfusion. 2015;55(6):1331-1339.

  44. Riff BP, Katona BW, Wilkerson M, Nathanson KL, Metz DC . HNPCC-associated pheochromocytoma: expanding the tumor spectrum. Pancreas. 2015;44(4):676-678.

  45. Henricks WH, Wilkerson ML, Castellani WJ, Whitsitt MS, Sinard JH. Pathologists as stewards of laboratory information. Arch Pathol Lab Med. 2015;139(3):332-337.

  46. Castellani WJ, Sinard JH, Wilkerson ML, Whitsitt MS, Henricks WH. Accreditation and regulatory implications of electronic health records for laboratory reporting. Arch Pathol Lab Med. 2015;139(3):328-331.

  47. Wilkerson ML, Henricks WH, Castellani WJ, Whitsitt MS, Sinard JH. Management of laboratory data and information exchange in the electronic health record. Arch Pathol Lab Med. 2015;139(3):319-327.

  48. Sinard JH, Castellani, Wilkerson ML, Henricks WG. Stand-alone laboratory information systems versus laboratory modules incorporated in the electronic health record. Arch Pathol Lab Med. 2015;139(3):311-318.

  49. Henricks WH, Wilkerson ML, Castellani WJ, Whitsitt MS, Sinard JH. Pathologists’ place in the electronic health record landscape. Arch Pathol Lab Med. 2015;139(3):311-318.

  50. Guha S, Liu H. Malakoplakia of the pancreas with simultaneous colon involvement: case report and review of the literature. Case Rep Pathol. 2015;2015:649136.

  51. Yu HE. Pitfalls of Point-of-Care Urinary Drug Screening for Pain Management. AACC Clinical Laboratory News. 2015;41:48.

  52. Boddicker RL, Kip NS, Xing X, Zeng Y, Yang ZZ, Lee JH, Almada LL, Elsawa SF, Knudson RA, Law ME, Ketterling RP, Cunningham JM, Wu Y, Maurer MJ, O'Byrne MM, Cerhan JR, Slager SL, Link BK, Porcher JC, Grote DM, Jelinek DF, Dogan A, Ansell SM, Fernandez-Zapico ME, Feldman . The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-?B positive feedback loop in peripheral T-cell lymphoma. Blood. 2015;125(20):3118-3127.

  53. Prichard JW, Davison JM, Campbell BB, Repa KA, Reese LM, Nguyen XM, Li J, Foxwell T, Taylor DL, Critchley-Thorne RJ. TissueCypher™: A systems biology approach to anatomic pathology. J Pathol Inform. 2015;6:48.

  54. Kim AH, Shellenberger MJ, Chen ZM, Li J. Case report of gastric outlet obstruction from metastatic lobular breast carcinoma. BMC Gastroenterol. 2015;15:120.

  55. Novak DJ, Bai Y, Cooke RK, Marques MB, et al. Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized, Optimal Platelets and Plasma Ratios (PROPPR) trial. Transfusion. 2015;55(6):1331-1339.

  56. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, et al. . Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015 Feb 3;313(5):471-82. JAMA. 2015;31395):471-482.

  57. Storm M, Kaspar HG, Nash JD, Gogoi R, Smith AL. Mixed Epithelial and Germ Cell Ovarian Cancer: A Case Report. Women Health Open J. 2015;1(2):45-47.

  58. Kimbason T, Turner SG, Kazmi SAJ, et al. Malignant Glioma with Primitive Neuroectodermal Components: Clinical and Pathologic Features with Treatment Modalities of Five Cases. J Clin Exp Pathol. 2015;5:6.

  59. Richardson A, Hossler E. Necrobiosis lipoidica diabeticorum. Cutis. 2015;95(5):252, 265-266.

  60. Saraiya A, Hall D, Hossler E. Erythematous papules and plaques on the flank of a child. Cutis. 2015;96(1):E1-E3.

  61. Isaacs M, Hossler E. Cutaneous leishmaniasis. Cutis. 2015;96(6):367, 408-409.

  62. Lin F, Chen ZM, Wang HL. Utility of immunohistochemistry in the pancreatobiliary tract.. Arch Pathol Lab Med. 2015;139(1):24-38.

  63. Chen ZM, Lin F. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.. Arch Pathol Lab Med. 2015;139(1):14-23.

  64. Liu H, Lin F. Application of immunohistochemistry in thyroid pathology. Arch Pathol Lab Med. 2015;139(1):67-82.

  65. Kaspar H, Crum CP. The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders. Arch Pathol Lab Med. 2015;139(1):39-54.

  66. Melnychuk E, Perlmutter A, Hossler E. A 38 year old man with extensor surface papules. JAMA. 2015;313(1):83-84.

  67. Cooper JD, Dorion RP, Smith JL. A rare case of Waterhouse-Friderichsen syndrome caused by Capnocytophaga canimorsus in an immunocompetent patient. Infection. 2015;Feb:13.

  68. Ferringer T. Immunohistochemistry in dermatopathology. Arch Pathol Lab Med. 2015;139(1):83-105.

  69. Zhu S, Schuerch C, Hunt J.. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. Arch Pathol Lab Med. 2015;139(1):55-66.

  70. Zsiros E, Duttagupta P, Lee H, Frank R, Garrabrant T, Hagemann IS, Dangaj D, Levine BL, June CH, Zhang L, Wang E, Marincola FM, Bedognetti D, Powell DJ, Tanyi J, Feldman MD, Kandalaft LE, Coukos G. CThe Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clin Cancer Res. 2015;21(12) :2840-2850. .

  71. Frank R, Dean SA, Kamoun M, Lal P.. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies. Cardiovasc Pathol. 2015;24(3):168-172.

  72. Hernandez, DR, Clark, AE, Johnson, DR, Olson, D., Wolk, DM. . T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2015;11:103-117.

  73. Beer T, Dorion RP. Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile. Hematol Rep. 2015;7(2):5893.

  74. Beer T, Dorion RP. A case of angiosarcoma metastatic to bone marrow. J Case Rep Onc Ther. 2015;1(1):010117.

  75. Cooper JD, Dorion RP, Smith JL. A rare case of Waterhouse-Friderichsen syndrome caused by Capnocytophaga canimorsus in an immunocompetent patient. Infecation. 2015;43(5):599-602.

  76. Lo SY, Baird GS, Greene DN. A roadmap to defining the clinical reportable ranges of chemistry analytes: Increasing automation efficiency and decreasing manual dilutions. Clinica Chimica Acta. 2015;451(Pt B):257-262.

  77. Diehl DL, Johal AS, Khara HS, Stavropoulos SN, Al-Haddad M, Ramesh J, Varadarajulu S, Aslanian H, Gordon SR, Shieh FK, Pineda-Bonilla JJ, Dunkelberger T, Gondim DD, Chen EZ. Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open. 2015;3(3):E210-5.

  78. Yu HE. Ask the Expert: Pitfalls of Point-of-Care Urinary Drug Screening for Pain Management. AACC Clin Lab News. 2015;41:48.

  79. Chen L, Huang K, Himmelfarb EA, Zhai J, Lai JP, Lin F, Wang HL. Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy. Hum Pathol. 2015;46(11):1647-1654.

  80. Kim V, Cornwell WD, Oros M, Durra H, Criner GJ, Rogers TJ. Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15:111.

  81. Kim V, Oros M, Durra H, Kelsen S, Aksoy S, Cornwell WD, Rogers TJ, Criner GJ. Chronic Bronchitis and Current Smoking Are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction. PLoS One. 2015;10(2):e116108.

  82. Norberg SM, Oros M, Manucha V, Eun D, Bilusic M. Loss of E-cadherin and Retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasis. Can J Urol. 2015;22(2):7755-7757.

  83. Lavelle JC, Grant ML, Karp, JK. Transfusion Related Acute Lung Injury in an era of TRALI risk mitigation. Immunohematology. 2015;31(4):155.

  84. Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, Vassallo R, Ryu JH, Yi ES.. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol. 2014;38(4):548-551..

  85. Norberg SM, Oros M, Birkenbach M, Billusic M. Spontaneous tumor lysis syndrome in renal cell carcinoma - a case eport. Clin Genitourin Cancer. 2014;12(5):e225.227.

  86. Oros ML, Chu E, Elenitsas R. Changing pigmentation in a solitary scalp lesion. Dermatol Online J. 2014;20:2.

  87. Heller JJ, Schjerven, H, Li S, Lee A, Qiu J, Chen Z, Smale ST, Zhou L. Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zink finger transcription factor Ikaros. J Immunol. 2014;193(8):3934-3946.

  88. Garcia-Carracedo D, Chen ZM, Qiu W, Huang AS, Tang SM, Hruban RH, Su GH. PIK3CA mutations in mucinous cystic neoplasms of the pancreas. Pancreas. 2014;43(2):245-249.

  89. Lobingier BT, Nickerson DP, Lo SY, Merz AJ. SM proteins Sly1 and Vps33 co-assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18. Elife. 2014;3:e02272.

  90. Nickerson DP, Russell MRG, Lo SY, Chapin H, Milnes J, Merz AJ. Termination of isoform-selective Vps21/Rab5 signaling at endolysosomal organelles by Msb3/Gyp3. Traffic. 2014;13(10):1411-1428.

  91. Wilkerson ML, Lin F, Liu H, Cheng L. The application of immunohistochemical biomarkers in urologic surgical pathology. Arch Pathol Lab Med. 2014;138(12):1643-1655.

  92. Boctor FN, Wilkerson ML. Fresh frozen plasma as a source of cholesterol for newborn with Smith-Lemli-Opitz syndrome associated with defective cholesterol synthesis. Ann Clin Lab Sci. 2014;44(3):332-333.

  93. Strickler AG, Vasquez JG, Yates N, Ho J. Potential Diagnostic Significance of HSP90, ACS/TMS1, and L-Plastin in the Identification of Melanoma. Mel Res. 2014;24(6):535-44.

  94. Strickler AG, Schaefer JT, Slingluff Jr MR, Wick MR. Immunolabeling for p16, WT1, & Fli-1 in the Assignment of Growth Phase for Cutaneous Melanomas. Amer J Dermatopathol. 2014;36(9):718-722.

  95. Frank R, Molina MR, Wald J, Goldberg LR, Kamoun M, Lal P. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy. Am J Clin Pathol. 2014;142(6):809-815 .

  96. Frank R, Li S, Ahmad NA, Shah P, Sepulveda AR, Jhala NC. Mesothelin expression in pancreatic mucinous cysts.. Am J Clin Pathol. 2014;142(3):313-319.

  97. Zhang L, Frank, R, Furth EE, Ziober AF, LiVolsi VA, Zhang PJ. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol. 2014;3:12.

  98. Surrey LF, Frank R, Zhang PJ, Furth EE. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol. 2014;38(2):224-227.

  99. Frank R, Baloch ZW, Gentile C, Watt CD, LiVolsi VA.. Multifocal fibrosing thyroiditis and its association with papillary thyroid carcinoma using BRAF pyrosequencing. Endocr Pathol. 2014;25(3):236-40.

  100. Lin F, Chen Z. Standardization of diagnostic immunohistochemistry: literature review and geisinger experience. Arch Pathol Lab Med. 2014;138(2):1564-1577.

  101. Zhang K, Deng H, Cagle PT. Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers: a review and update. Arch Pathol Lab Med. 2014;138(12):1611-1628.

  102. Lastra RR, Pramick MR, Crammer CJ, LiVolsi VA, Baloch ZW. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience. Cancer Cytopathol. 2014;122(10):734-744.

  103. Malo J, Luraschi-Monjagatta C, Wolk DM, Thompson R, Hage CA, Knox KS. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014;11(2):243-253.

  104. Schieffer KM, Tan KE, Stamper PD, Somogyi A, Andrea SB, Wakefield T, Romagnoli M, Chapin KC, Wolk DM, Carroll KC. Multicenter evaluation of the Sepsityper™ extraction kit and MALDI-TOF MS for direct identification of positive blood culture isolates using the BD BACTEC™ FX and VersaTREK(®) diagnostic blood culture systems. J Appl Microbiol. 2014;116(4):934-941.

  105. Zhang XM, Aguilera N. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma. Arch Pathol Lab med. 2014;138(12):1666-1672.

  106. Patel A, Bishburg E, Zucker M, Tsang P, Nagarakanti S, Sabnani I. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient. Heart Lung. 2014;43(6):506-509.

  107. Wang H, D'Cruz C, Yam DC, Dilla LM, Tsang P. Learning curve for endobronchial ultrasound-guided transbronchial needle aspiration: experience of a community-based teaching hospital. Mol Med Rep.. 2014;10(5):2441-2446.

  108. Wang H, Tsang P, D'Cruz C, Clarke K. Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population. Diagn Pathol. 2014;9:86.

  109. Mazack, V; Sudol M; Kaspar H; Nash J; Carey DJ; Gogoi R. Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer. PLoS ONE. 2014;9(6):e100974.

  110. Fairley KJ, Li J, Komar M, Steigerwalt N, Erlich P. Predicting the risk of recurrent adenoma and colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol. . 2014;5:e64.

  111. Prichard JW. Overview of automated immunohistochemistry. Arch Pathol Lab Med. 2014;138(12):1578-82.

  112. Fussell J, Troutman D, Hossler E, Agarwal S. Malignant melanoma presenting as a non-healing heel ulceration. J Am Podiatr Med Assoc . 2014;104(3):295-297.

  113. Alexander WS, Hossler E. Asymptomatic facial papules. J Am Acad Dermatol. 2014;71(2):412-414.

  114. Pfingstler LF, Hossler EW. The skinny on psoriasis and weight loss. Surg Obes Relat Dis. 2014;10(6):1159-1160.

  115. Hall LD, Ferringer T. Solitary adult myofibroma. Cutis. 2014;93(5):225, 235-6..

  116. Sivendran M, Fu Y, deMoll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer T, Tismenetsky M, Tsui C, Friedlander P, Parides M, Banchereau J, Chaussabel D, Lebwohl M, Wolchok J, Bhardwaj N, Burakoff S, Oh W, Palucka K, Merad M, Schadt E, Saenger Y. Dissection of immune gene networks in primary melanoma tumors critical for anti-tumor surveillance of patients with stage II-III resectable disease. J Invest Dermatol. 2014;134(8):2202-2211.

  117. Prickett K, Ferringer T. Helminths – A Clinical Review and Update. Semin Cutan Med Surg. 2014;33(3):128-32.

  118. Liu H. Application of immunohistochemistry in breast pathology – a review and update. Arch Pathol Lab Med. 2014;138(12):1629-1642.

  119. Wilkerson M, Liu H, Lin F, Cheng L. Genitourinary System (Urinary Bladder, Testis, Prostate and Kidney). Review article. Arch Pathol Lab Med. 2014;138(12):1643-1665.

  120. Cole C, Ferringer T. Histopathologic Evaluation of the Sentinel Lymph Node for Malignant Melanoma: The Unstandardized Process. Am J Dermatopathol. 2014;36(1):80-87.

  121. Martinez RM. Genes in your tissue: probe identification and sequencing microbial targets from formalin-fixed, paraffin-embedded tissue. Clin. Microbiol. Newslett. 2014;36:139-147.

  122. Zuckerman R, Manji K, Matee M, Naburi H, Bisimba, J, Martinez R, Wieland-Alter W, Kim F, von Reyn CF, Palumbo P. HSV oropharyngeal shedding among HIV-infected children in Tanzania. Int J STD AIDS. 2014;Epub ahead of print:DOI: 10.1177/0956462414543122.

  123. Martinez RM, Bauerle ER, Butler-Wu SM. Evaluation of Three Rapid Diagnostic Assays to Directly Identify Organisms from Positive Blood Cultures. J Clin Microbiol. 2014;52:2521-2529.

  124. Martinez RM, Hulten KG, Bui U, Clarridge III JE. Molecular analysis of Lactobacillus spp. diversity in clinical specimens associated with disease. J Clin Microbiol. 2014;52:30-36.

  125. Cunningham A. Martinez RM, Hernandez DR and Wolk DM. Microbial biorepositories in clinical microbiology. Clin Microbiol Newslett. 2014;36:41-48.

  126. Luong-Player A, Liu H, Wang HL, Lin F. Immunohistochemical re-evaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues. Am J Clin Pathol. 2014;141:219-225.

  127. Zhang PL, Mashni JW, Sabbisetti VS, Schworer CM, Wilson GD, Wolforth SC, Kernen KM, Seifman BD, Amin MB, Geddes TJ, Lin F, Bonventre JV, Hafron JM. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol. 2014;46(2):379-88.

  128. Lai JP, Chen ZM, Lok T, Chan OT, Himmelfarb E, Zhai Q, Lin F, Wang HL. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions. J Clin Pathol. 2014;67(6):464-469.

  129. Lin F, Shi J, Zhu S, Chen Z, Li A, Chen T, Wang HL, Liu H. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014;138:1015-1026.

  130. Lok T. Chen L, Lin F, Wang HL. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Hum Pathol. 2014;45:394-400.

  131. Liu H, Shi J, Prichard JW, Gong Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol. 2014;141:648-655.

  132. Shieh FK, Luong-Player A, Khara HS, Liu H, Lin F, Shellenberger MJ, Johal AS, Diehl DL. Improved endoscopic retrograde cholangiopancreatography brush increases diagnostic yield of malignant biliary strictures. World J Gastrointest Endosc. 2014;6(7):266-333.

  133. Lin F, Liu H. Iimmunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. . Arch Pathol Lab Med. 2014;138(12):1583-1610.

  134. Lin F. Evolving practices of diagnostic immunohistochemistry. Arch Pathol Lab Med. 2014;138(12):1561-1563.

  135. Martin KL, Firestone DE, McGarry SV, Dorfman HD, Kazmi SAJ. Chondroblastoma-like osteosarcoma. Pathol Int. 2014;64:409-411.

  136. Maleszewski JJ, Larsen BT, Kip NS, Castonguay MC, Edwards WD, Carney JA, Kipp BR.. PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors. Am J Surg Pathol. 2014;38(8):1079-1087.

  137. Vaughan EM, You JS, Yu HE, Lasek A, Vitale N, Hornberger T & Bement WM. Lipid domain-dependent regulation of single cell wound repai. Mol Biol Cell. 2014;25:1867-1876.

  138. Malo J, Luraschi-Monjagatta C, Wolk DM, Thompson R, Hage CA, Knox KS.. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014;11(2):243-53.


Other Publications:

  1. Yu HE, Wilkerson M. Employee Engagement is vital for the Successful Selection of a Total Laboratory Automation System. Lab Med. https://doi.org/10.1093/labmed/lmx030; In press, 2017.

  2. Yu HE. Pharmacogenetics for Drug Hypersensitivity Reactions. AACC Pearls of Laboratory Medicine. https://doi.org/10.15428/cctc/2015/252858; --, 2017.

  3. Spinosa JC, Arnaout R, Berman MA, Birdsong G, Boguski MS, Booker D, Carter A, Castellani W, Chen D, Chen P, Dash RC, de Baca M, Elevitch F, Gilbertson J, Harrison J, Henricks W, Kennedy M, Knapik C, Olson JE, Robb J, Routbort M, Rudolf JW, Simpson RW, Sinard J, Wilkerson M. CAP Pathology Resource Guide: Clinical Informatics. CAP Pathology Resource Guide. Clinical Informatics; Version 1.0 , 2016.

  4. Kip NS. Molecular techniques using nucleic acids. Nanostring. Oral presentation; Webinar, 2016.

  5. Chen ZE, Liu H, Wilkerson ML. Archives Applied – Evolving Practices of IHC in Breast, Genitourinary, Gastrointestinal, and Liver Pathology. College of American Pathologists. Online CME; Self-Assessment Module, 2015.

  6. Balakrishna J, DePond W, Reddi D, Sharabi A, Tsang, P. Lymph nodes - not lymphoma. www.pathologyoutlines.com/lymphnodes.htm. Pathology Outlines; November, 2015.

  7. Gray A, Hossler E, Lin G. Nodule on the scalp of a 76-year-old male. ASDP Interactive case study of the month. http://www.asdp.org/education/case-study-of-the-month/public-case-study/?caseID=49. July; 2015, 2015.

  8. Shockman S, Ferringer T. Crusted plaque on the cheek of a medical student. ASDP online interactive case study. ASDP online interactive case study. http://www.asdp.org/education/case-study-of-the-month/public-case-study/?caseID=41; March, 2015.

  9. Cooper JD, Dometita D, Hasan A, Dorion RP, Wolk DM, Martinez RM. "Orange" you glad you checked the buffy coat. Clinical Microbiology Newsletter. 37(2); 9-13, 2015.

  10. Egnatios GL, Ferringer T, Dorion RP. Multiple skeletal fractures and asymptomatic foot nodule.. ASDP . Online Interactive Case Study; April, 2014.

  11. Eminger L, Ferringer T. Speckeled pigmented patch. ASDP. Online Interactive Case Study; February, 2014.


Books and Book Chapters:

  1. Lin F, Prichard JW, Liu H, Wilkerson M, Chen Z, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  2. Chen ZM, LI J, Lin F. Lower gastrointestinal tract. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  3. Chen ZM, Prichard J, Lin F. Liver, Bile Ducts and Gallbladder. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  4. Lin F, Wang HL. Pancreas and ampullae. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  5. Chen ZM, Lin F. Overview of Predictive Biomarkers and Integration of IHC into Molecular Pathology. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  6. Dorion RP, Zhang X. Bone Marrow. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  7. Ferringer T. Skin. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  8. Ferringer T, Ko CJ. The basics: DIagnostics terms, skin anatomy and stains. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  9. Ferringer T. Granulomatous and histiocytic diseases. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  10. Ferringer T. Genodermatoses. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  11. Ferringer T. Alterations in collagen and elastin. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  12. Ferringer T. Metabolic disorders. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  13. Ko CJ, Ferringer T. Key diagnostic features of soft tissue neoplasms. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  14. Ferringer T. Tumors of fat, muscle, and bone. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  15. Ferringer T. Neural tumors. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  16. Ferringer T. External agents and artifacts. In Elston D, Ferringer T, eds. Dermatopathology, 2nd ed.. Elsevier. London. 2014.

  17. Ferringer T, Elston D, et al. Tissue or Cell-Based Techniques. In Gao Xing-Hua, Chen Hong-Duo, eds. Practical Immunodermatology. Springer. Netherlands. 2016.

  18. Ferringer T. Immunohistology and Molecular Studies of Smooth Muscle and Neural Cutaneous Tumors. In Plaza JA, Prieto V, eds. Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Springer. Switzerland. 2016.

  19. Kaspar HG, Crum CP. Uterus. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  20. Kazmi S, Wu H, Schuerch C. Central Nervous System. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  21. Li JH, Lin F. Upper gastrointestinal tract. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  22. Lin F, Yang X. Kidney. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  23. Lin F, Liu H. Unknown primary/undifferentiated neoplasms in surgical and cytologic specimens. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  24. Lin F, Prichard J, Bitting AK, et al.. Geisinger Immunohistochemical Antibodies and Staining Protocols. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  25. Lin F, Shi J. Standardization of diagnostic immunohistochemisry. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  26. Lin F, Prichard J, Bitting A, Shi J, Liu H, Wilkerson M, Chen Z. Geisinger immunohistochemical antibodies and staining protocols. In Lin F, Prichard JW, Liu H, Wilkeson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions. 2nd ed.. Springer. New York. 2015.

  27. Liu H, Lin F, QiHui Z. Prostate Gland. In Lin F, Prichard JW, Liu H, Wilkeson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions. 2nd edition. Springer. New York. 2015.

  28. Liu H, Wilkerson M, Lin F. Thyroid, parathyroid, and adrenal gland. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  29. Liu H. Breast. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  30. Whitfield NN, Martinez RM, Wolk DM. Clinical microbiology: looking ahead. In Truant AL, eds. Manual of Commercial Methods in Clinical Microbiology. 2nd ed. ASM Press. Washington DC. 2014.

  31. Meschter SC, Silverman JF. Exfoliative cytology and effusions. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  32. Prichard J, Hicks DG, Hammond EH. Predictive Biomarkers in Breast Cancer: ER, PR and Her-2/neu. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  33. Prichard JW, Kaspar HG. Ovary. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  34. Prichard J. Immunohistochemistry Quality Management. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  35. Prichard J, Bitting AK. Automated immunohistochemistry overview. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  36. Prichard JW, Tomsho N, Yeager L. Quality management in intraoperative consultations. In Nakleh RW, eds. Quality management in anatomic pathology: promoting patient safey through systems improvement and error reduction 2nd edition. College of American Pathologists. Northfield, Illinois. 2017.

  37. Schuerch C, Zhu S. Salivary Glands and Head and Neck. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  38. Miziguchi RS, Strickler AG. Amyloidosis. In Kelly AP, Taylor SC, Lim HW, Anido Serran AM, eds. Dermatology for Skin of Color, 2nd ed. McGraw-Hill Education. New York, NY. 2016.

  39. Tyler WB. Application of Direct Immunofluorescence for Skin and Mucosal Biopsies. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  40. Wehler A, Fakhry SM. Transfusion Therapy: When to Use It and How to Minimize It. In Gabrielli A, Layon AJ, Yu M, eds. Civetta, Taylor, and Kirby’s Manual of Critical Care. Lippincott Williams & Wilkins . Philadelphia, PA. 2017.

  41. Wilkerson M, Cheng L. Urinary Bladder and Urachus. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  42. Wilkerson M, Cheng L. Testis and paratesticular tissue. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  43. Wilkerson M, Hewitt S. Tissue Microarray. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  44. Hayden RH, Tang Y, Carroll K, Wolk DM, eds. Diagnostic Microbiology of the Immunocompromised Host, 2nd ed. ASM Press. Washington, DC. 2015.

  45. Marlowe EM, Wolk DM. Molecular Method Verification and Biostatistics for Laboratory Diagnostics. In Persing D, eds. Molecular Microbiology: Diagnostic Principles and Practice 3rd ed. ASM Press. Washington, DC. 2016.

  46. Whitfield NN and Wolk DM. Quantitative PCR. In ASM, eds. Clinical Virology Manual. ASM Press. Washington, DC. 2016.

  47. Yin H, Paynton B, Zelonis M, Snyder D, Kip N. Application of Fluorescent in Situ Hybridization (FISH) in Surgical. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  48. Zhang K, Deng H, Cagle P. Pleuropulmonary and Mediastinal Neoplasms. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  49. Zhang X, Aguilera N. Lymph Node. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.

  50. Zhang K, Chen S, eds. Practical Pathologic Diagnosis of Lymphoma. Science Press. China. 2015.

  51. Zhu S, Miettinen M, Lin G. Soft Tissue and Bone Tumors. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer. New York. 2015.


Abstracts, Posters, and Other Presentations:

  1. Grant ML, Sidiropoulos N. Implementation Consideration: Designing and Medically Vetting a Targeted Gene Panel for Hematologic Malignancies. Platform Presentation. Assocation of Molecular Pathology (AMP) Annual Meeting, Salt Lake City, Utah, November 2017.

  2. Tsang P, Harrison HH, Perry D, Olson J, Dorion P, Schuerch C. Heparin-Induced Thrombocytopenia: Optimizing Laboratory Utilization and Anticoagulation Stewardship. Abstract (submitted). American Society for Clinical Pathology Annual Meeting, National Harbor, Maryland, October 2017.

  3. Zhang XM, Tsang P. IMP3/KOC1, a New Immunohistochemical Marker for Differentiating Classical Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma from Diffuse Large B-Cell Lymphoma. Abstract (submitted). American Society for Clinical Pathology Annual Meeting, Chicago, Illinois, September 2017.

  4. Harrison HH, Tutaeva V, Dorion RP, Haynes AE, Schuerch C, Tsang P, Zhang K, Zhang X, Hematopathology Utilization Team, Kip NS. Utilization of Fluorescent In Situ Hybridization (FISH) Probe Panels in Routine Clinical Hematopathology Practice: Lymphoid and Plasma Cell Disorders. Abstract (submitted). American Society for Clinical Pathology Annual Meeting, Chicago, Illinois, September 2017.

  5. Yu HE. Strategy for Provider-Performed Microscopy Testing Competency Management. Speaker. American Association of Clinical Chemistry Annual Meeting, San Diego, California, July 30-August 3, 2017.

  6. Lin F. The Third CAPA-China Pathology meeting. Organizer. CAPA, San Antonio, Texas, March 4, 2017.

  7. Lin F, et al. Detection of albumin expression by RNA in situ hybridization is a sensitive and specific method for identification of hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  8. Piazza Y, Liu H, Lin F. Immunohistochemical Detection of Loss Expression of ATRX/DAXX in Neuroendocrine Tumors from Various Organs. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  9. Swarrow RS, Liu H, Lin F. Diagnostic Utility of VHL, Maspin, IMP3 and S100P in the Evaluation of Pancreatic Resection Margins from Frozen Tissue. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  10. Piazza Y, Lin F, Liu H. The Correlation of Afirma® Gene Expression Classifier Results with Follow-Up Findings for Thyroid Fine Needle Aspiration Specimens. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  11. Swarrow RS, Lin F, Liu H. Analysis of the atypia of undetermined significance/follicular lesion of undetermined significant (AUS/FLUS) category – experience from a large health system. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  12. Chen ZE, Bitting A, Lin F. Assessment of PD-L1 expression in tumor microenvironment of mismatch repair deficient colon cancer: comparing two antibody clones, SP142 vs. SP263. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  13. Zhang S, Liu F, Shi J, Chi P, Lin F, Stellino A, Shen H, Wang HL. Diagnostic Value of Clusterin Immunostaining in Hepatocellular Carcinoma: A Comparison with pCEA and CD10. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  14. Liu H, Wilkerson M, Lin F. NKX3.1 is the Most Sensitive Immunohistochemical Marker in Identifying Metastatic Prostatic Carcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  15. Liu H, Wilkerson M, Lin F. Immunohistochemical Evaluation of NKX3.1 Expression in Prostatic Ductal Adenocarcinomas. Poster presentation. United States and Canadian Academy of Pathology, San Antonio, Texas, March 4-10, 2017.

  16. Fagan J, Kass A, Larsen D, Hossler E. The cost of a Skin Biopsy: Price Transparency and Variability in Dermatology. Presentation. Presented at the AAD 2017 meeting, Orlando, FL, March 4, 2017.

  17. Hossler E, Marks K, Palmer M, Pride H. Highlights from the medical and pediatric literature. Presentation. Presented at the AAD 2017 meeting, Orlando, FL, March 3, 2017.

  18. Brooks J, Showan N, Chandler E, W. Biopsy site verification using dermoscopic photographs and histology. Poster. American Academy of Dermatology meeting, Tampa, Florida, March 3-7, 2017.

  19. Strickler, AG. Conquer the boards: An experiential review. Invited talk. American Academy of Dermatology Annual Meeting, Orlando, Florida, March 2017.

  20. Ferringer TC. Self-Assessment Course. Course. Joint Meeting of the International Society of Dermatpathology , Orlando, Florida, March 2017.

  21. Ferringer TC. Closing the Gender Gap in Academic Dermatology and Dermatology Leadership: Problems and Solutions – Time Management. Speaker. American Academy of Dermatology Annual Meeting , Orlando, Florida, March 2017.

  22. Ferringer TC. Help Your Dermatopathologist Work Smarter for You . Speaker. American Academy of Dermatology Annual Meeting , Orlando, Florida, March 2017.

  23. Ferringer TC. Infectious Diseases-Barnyard Zoonoses . Speaker. American Academy of Dermatology Annual Meeting , Orlando, Florida, March 2017.

  24. Ferringer TC. What’s New in Dermatopathology-Immunohistochemistry . Speaker. American Academy of Dermatology Annual Meeting , Orlando, Florida, March 2017.

  25. Ferringer TC. Essentials in Dermatopathology-Metabolic Disease . Speaker. American Academy of Dermatology Annual Meeting , Orlando, Florida, March 2017.

  26. Ferringer TC. Dermatopathology Case Challenge: Mimics and Masqueraders . Speaker. American Academy of Dermatology Annual Meeting , Orlando, Florida, March 2017.

  27. Prichard JW, Meschter SC. Short Course 54: Practical Informatics Solutions for Anatomic Pathology Quality Management. Short Course. United States and Canadian Academy of Pathology , San Antonio, Texas, March 4-10, 2017.

  28. Kip NS, Tutaeva V, Prichard JW, Leeming R, Arora TK, Vogel VG. Validation of Prosigna (Breast Cancer Prognostication Assay) & Its Concordance with Oncotype DX & Mammoprint: Geisinger Health System’s Experience. Preseentation. United States & Canadian Academy of Pathology’s 106th Annual Meeting, San Antonio, Texas, March 4-10, 2017.

  29. Marshall KA, Kethireddy S, Brown AM, Prichard JW, Wilkerson ML. Crowdsourcing to Create Structured Data Sets for Quality Improvement. Presentation. AMIA Joint Summits on Translational Science, San Francisco, California, March 27-30, 2017.

  30. Zhang X, Deng H. Different Expression of Prognostic Markers in Invasive Ductal Carcinoma with or without Nodal Metastasis. Poster presentation . 34th annual Miami Breast Cancer conference, Miami, Florida, March 9-12, 2017.

  31. Ferringer TC. Infections and Infestations. Speaker. Annual Dermatopathology Super Symposium , Albert Einstein College of Medicine, January .

  32. Ferringer TC. CPC: Great Cases from the Dermatopathology Group. Speaker. Geisinger Pathology Tuesday Noon Conference, Geisinger Medical Center, Danville, Pennsylvania, December 2016.

  33. Ferringer TC. Clinicopathologic Correlation. Visiting Professor. Grand Rounds, Department of Dermatology, Virginia Commonwealth University, December 2016.

  34. Corbali MO, Metpally R, Williams H, Krishnamurthy S, Harrison H, Carey DJ, Williams MS, Baras A, Overton J, Kip NS. Decoding 51 Thousand Individuals to Analyze the Most Common Genetic Disorder: Hereditary Hemochromatosis (HH). Platform presentation. Association for Molecular Pathology , Charlotte, North Carolina, November 10-12, 2016.

  35. Lin F. The Second CAPA Diagnostic Pathology Course . Organizer. CAPA, Houston, Texas, November 12, 2016.

  36. Yu HE. Learning to Speak the Language of Procalcitonin – Geisinger Health System’s Strategy for Realizing the Full Clinical Utility of Procalcitonin. Webinar Series. Compass Group, , October 2016.

  37. Vidas J, Grant ML, Harach M, Loos K, Karp JK. Retrospective Email Notification of Inappropriate Plasma Transfusions: A Performance Improvement Study. Poster. American Association of Blood Banks Annual Meeting, Orlando, Florida, October 2016.

  38. Karp JK, Grant ML, Gould J, Hall NE, Herman JH. Much Ado About Nothing: Preparations Before and Lessons Learned After the Papal Visit. Poster. American Association of Blood Banks Annual Meeting, Orlando, Florida, October 2016.

  39. Grant ML, Pirilli A, Karp JK. You're a Lifesaver- Blood Donor Feedback on Email Notification of the Specific Date Donor Units Were Transfused. Poster. American Association of Blood Banks Annual Meeting, Orlando, Florida, October 2016.

  40. Grant ML, Karp JK, Drelich D, Herman JH. Fibrinogen Content of Prepooled Cryoprecipitate: The First Step to Establishing Dosage and Pharmacoeconomic Equivalency with Fibrinogen Concentrates. Poster. American Association of Blood Banks Annual Meeting, Orlando, Florida, October 2016.

  41. Kip NS, Corbali MO, Metpally R, Williams H, Krishnamurthy S, Harrison H, Carey DJ, Williams MS, Baras A, Overton J. Decoding 51 Thousand Individuals to Analyze the Most Common Genetic Disorder: Hereditary Hemochromatosis (HH). Platform presentation. American Society of Human Genetics, Vancouver, British Columbia, October 18-22, 2016.

  42. Metpally R, Williams H, Krishnamurthy S, Harrison H, Kip NS, Carey DJ, Baras A, Overton J. Germline Mutation Burden in Hereditary Cancer Predisposing Genes: Pan-Cancer Analysis of the 51,289 individuals from the DiscovEHR study. Presentation. American Society of Human Genetics, Vancouver, British Columbia, October 18-22, 2016.

  43. Ferringer TC. Pediatric Dermatopathology. Sepaker. International Society of Dermatopathology Symposium, Lima, Peru, October 2016.

  44. Ferringer TC. Short Course I Best Practices: From Guidelines to Appropriate Use. Course Director. American Society of Dermatopathology Annual Meeting , Chicago, Illinois, October 2016.

  45. Ferringer TC. Short Course IV Update in Cutaneous Lymphoma. Course Director. American Society of Dermatopathology Annual Meeting , Chicago, Illinois, October 2016.

  46. Ferringer TC. Massive localized lymphedema: An emerging, reactive, soft tissue complication of the morbidly obese. Poster. American Society of Dermatopathology Annual Meeting , Chicago, Illinois, October 2016.

  47. Green A, Mowad C, Ferringer T. Galli-Galli disease: A rare acantholytic variant of Dowling-Degos disease. Duel. American Society of Dermatopathology Annual Meeting , Chicago, Illinois, October 2016.

  48. Schleich C, Ferringer TT. Mycobacterial Spindle Cell Pseudotumor. Poster. American Society of Dermatopathology Annual Meeting , Chicago, Illinois, October 2016.

  49. Prichard JW. Pathology Perspective on Papillary Lesion of the Breast. Invited Lecture. Geisinger 2016 Annual Breast Cancer Conference, Danville, Pennsylvania, October 8, 2016.

  50. Prichard JW. ER PR and HER2 Testing. Invited Lecture. Geisinger Seminar in Anatomic Pathology, Danville, Pennsylvania, September 16, 2016.

  51. Zhang X, Zhang K. Correlation of Immunohistochemistry and Proliferation Rate/Aggressive Behavior in Diffuse Large B-cell Lymphoma. Poster presentation LYS-P-5. XVIII meeting of the European association for Haematopathology, Basel, Switzerland, September 3-8, 2016.

  52. Zhang K, Zhang X. Clinicopathologic Features and Outcome of 15 cases of Double Hit Lymphoma (DHL) and Atypical DHL (aDHL). Poster presentation . XVIII meeting of the European association for Haematopathology, Basel, Switzerland, September 3-8, 2016.

  53. Ferringer T. Immunohistochemical Markers in Skin. Lecture. Geisinger Seminar in Anatomic Pathology, Danville, Pennslyvania, September 2016.

  54. Chivukula M, Kip NS, Vishnu P. Next Generation Sequencing (NGS) Testing in Cancer Diagnostics: Promise and Perils. Panel Discussion. American Society for Clinical Pathology, Las Vegas, Nevada, September 13-17, 2016.

  55. Fagan J, Kass A, Larsen D, Hossler E. The cost of a Skin Biopsy: Price Transparency and Variability in Dermatology.. Presentation. Pennsylvania Academy of Dermatology, Bedford Springs, PA, September 2016.

  56. Li Y, Luo X, Liu S, James I, Morewood G, Grant ML, Simmons-Massey K, Nikolaidis S, Nance S, Moolten DN. Necessity of Tube Method in RBC Antibody Screen: Perspective from a Case of Cold Agglutinin Disease. Poster. International Society of Blood Transfusion Annual Meeting, Dubai, United Arab Emirates, September 2016.

  57. Hu L, Liu H, Lin F. Re-evaluation and Identification of the Most Effective Immunohistochemical Panel in Distinguishing Papillary Renal Cell Carcinoma from Papillary Urothelial Carcinoma. Poster Presentation. College of American Pathologists, Las Vegas, Nevada, September 24-28, 2016.

  58. Liu H, Shi J, Lin F. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of GCDFP15 expression in breast carcinomas. . Poster presentation. College of American Pathologists, September 24-28, 2016, Las Vegas, Nevada.

  59. Lin F. The First Geisinger Annual Pathology Seminar. Course Director. Pathology Seminar, Geisinger Medical Center, September 16-18, 2016.

  60. Lin F. Undifferentiated carcinoma: using IHC approach. Lecture. The First Geisinger Annual Pathology Seminar , Geisinger Medical Center, September 16, 2016.

  61. Lin F. Chinese American Pathologists Association Companion meeting. Organizer. Chinese American Pathologists Association Companion meeting at the CAP 2016 annual meeting , Las Vegas, Nevada, September 24, 2016.

  62. Harrison HH, Dorion RP, Kip NS, Tsang P, Wehler A, Zhang K, Zhang M. Statistical benchmarks for HemeFISH utilization in a multi-hospital integrated delivery system. Abstract. CAP Annual Meeting, Las Vegas, NV, September 25-28, 2016.

  63. Harrison HH, Adler M, Kimmich, D, Knowles-Tuchman M, Costello D, Nowack, R, Mika A, Rockwell S, Shaeffer L, Dorion P, Grifone T, Olson J, Tsang P, Wilkerson M, Yu E, and the Analytical QC Team. Use of Sigma-based QC to monitor hematology and coagulation testing in an expending, multi-instrument, multi-site, integrated healthcare system. Abstract. AACC Annual Meeting, Philadelphia PA, July 31-August 4, 2016.

  64. Ferringer T. Clinicopathologic Self-Assessment. MOC, director and speadker. American Academy of Dermatology Summer Meeting, Boston, Massachusetts, July 2016.

  65. Ferringer T. PACE: Your True Colors: Know Yourself and Understand Others. co-Director. American Academy of Dermatology Summer Meeting, Boston, Massachusetts, July 2016.

  66. Vidas J, Grant ML, Harach M, Loos K, Karp JK. Retrospective Email Notification of Inappropriate Plasma Transfusions: A Performance Improvement Study. Poster. Thomas Jefferson University Hospital’s Housestaff Quality and Safety Poster Day, Philadelphia, Pennsylvania, June 2016.

  67. Lin F. Updates on new antibodies on FNA and small tissue biopsies. Presentation. The Association of Chinese American Physicians, New York, New York, May 22, 2016.

  68. Critchley-Thorne RJ, Duits LC, Prichard JW, Davison JM, Jobe BA, Campbell B, Zhang Y, Repa K, Reese L, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Zaidi A, Taylor DL, Rustgi AK, Bergman J, Falk GW. A Novel Tissue Systems Pathology Test Predicts Progression in Barrett's Esophagus Patients. Lecture presentation. Digestive Disease Week, San Diego, California, May 21-24, 2016.

  69. Critchley-Thorne RJ, Davison JM, Prichard JW, Li J, Diehl DL, Reese L, Zhang Y, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi A, Duits LC, Bergman J, Rustgi AK, Falk GW. A Tissue Systems Pathology Test Detects a Field Effect Associated with High Grade Dysplasia and Esophageal Cancer in Barrett’s Esophagus Patients. Poster. Digestive Disease Week, San Diego, CA, May 21-24-2016.

  70. Martinez RM, Kay HE, Scicchitano LM, Wolk DM. Implementation of non-batched respiratory virus assay significantly impacts patient outcomes in the ICU. Abstract. Pan American Society for Clinical Virology, Daytona Beach, FL, May 19-22, 2016.

  71. Styer AM, Rygalski KS, Scicchitano LM, Wolk DM. Verification of T2Candida Panel for the identification of Candida species in EDTA-preserved whole blood. Abstract. Inaugural ASM Microbe Meeting, Boston, MA, June 16-20, 2016.

  72. Johnson JK, Albrecht V, Karlsson M, Robinson G, Stevens V, Werner B, Schuetz A, Wolk DM, Marlowe E, Babady E, Miller M, Culbreath K, Butler-W S, Diekema D, Rasheed JK, Limbago B. Detection of CREs in US Clinical Laboratories. Abstract. Inaugural ASM Microbe Meeting, Boston, MA, June 16-20, 2016.

  73. Martinez RM, Shoemaker B, Riley J, Wolk DM. The TeleGram© of the 21st Century: the Digital Gram Stain. Abstract. Inaugural ASM Microbe Meeting, Boston, MA, June 16-20, 2016.

  74. Martinez RM. Clinical Microbiology: Saving Lives and Solving Problems. Seminar Series. California State University, Northridge Biology Department Spring Seminar Series, Northridge, CA, April 22, 2016.

  75. Martinez RM. Reinventing the TeleGram©: Improving Patient Care Through Digital Technology. Presentation. ASCLS-PA Annual Spring Meeting , Harrisburg, PA, April 13, 2016.

  76. Vidas J, Grant ML, Harach M, Loos K, Karp JK. Retrospective Email Notification of Inappropriate Plasma Transfusions: A Performance Improvement Study. Poster. Thomas Jefferson Pathology Honors Program Student Research Symposium, Philadelphia, Pennsylvania, April 2016.

  77. Ferringer T. Immunohistochemistry in dermatopathology. Guest speaker. German Society of Dermatopathology, Hildesheim, Germany, April 2016.

  78. Ferringer T. Leadership forum. Chair. AAD Leadership Forum, Itasca, IL, April 2016.

  79. Ferringer T. Real World Dermatology for Residents … What You Really Need To Know. Speaker. Dermatopathology Clues, Las Vegas, NV, April 2016.

  80. Ferringer T. Dermatology Teachers Exchange Group. Course Director. AAD Annual Meeting, Washington, DC, March 2016.

  81. Ferringer T. Basic Dermatopathology Self-Assessment. Speaker. AAD Annual Meeting, Washington, DC, March 2016.

  82. Ferringer T. Infectious Diseases . Speaker. AAD Annual Meeting, Washington, DC, March 2016.

  83. Ferringer T. What’s New in Dermatopathology: What Are You Missing in the Surgical Pathology Literature. Speaker. AAD Annual Meeting, Washington, DC, March 2016.

  84. Ferringer T. Essentials in Dermatopathology-Metabolic Disease. Speaker. AAD Annual Meeting, Washington, DC, March 2016.

  85. Ferringer T. Pearls for the Posters. Co-Director. AAD Annual Meeting, Washington, DC, March 2016.

  86. Schleich C, Ferringer T, Petrick M. Plaque type syringoma mimicking a microcystic adnexal carcinoma. Poster. AAD Annual Meeting, Washington, DC, March 2016.

  87. Cohen S, Palmer M, Hossler E, Ferringer T. Pustular acrodermatitis enteropathica-like eruptions in the setting of total parenteral nutrition. Poster. AAD Annual Meeting, Washington, DC, March 2016.

  88. Spiker A, Pride H, Ferringer T. Papular epidermal nevus with “skyline” basal cell layer. Poster. AAD Annual Meeting, Washington, DC, March 2016.

  89. Yakish K, Mowad C, Marks VJ, Ferringer T. Management of subcutaneous phaeohyphomycosis via Mohs micrographic surgery. Poster. AAD Annual Meeting, Washington, DC, March 2016.

  90. Ferringer T. The torment of scabies: clues and dangers. Presentation. International Society of Dermatopathology 19th Joint Meeting, Washington, DC, March 2016.

  91. Chen Z, Li H, Kip NS, Lin F. Detection of mismatch repair protein (mmr) loss by immunohistochemistry (IHC) in colorectal adenomas from young patients: an appraisal of its utility in lynch syndrome screening. Abstract/Presentation. USCAP Annual Meeting, Seattle, WA, March 2016.

  92. Zhou W, Koo J, Wang HL, Liu H, Chen Z, Lin F. Diagnostic utility of clusterin immunostaining in differentiating hepatocellular carcinoma from tumors of other origins. Abstract/Presentation. USCAP Annual Meeting, Seattle, WA, March 2016.

  93. Kip NS, Chen M. Quality Assurance Aspects of implementing BRAFV600E Immunohistochemistry (IHC) Assay in Universal Lynch Syndrome Screening (ULS) for Colorectal Cancer (CRC): A Single Institution Experience. Abstract. USCAP, Seattle, WA, March 12-18, 2016.

  94. Shipp D, Pride H Lin G. Erythematous Evanescent Morbilliform Rash. Poster. AAD Annual meeting, Washington, DC, March 4-8, 2016.

  95. Kip NS. Clinical Informatics: Returning Results from Big Data. Oral presentation. Molecular Med TricCon Meeting, San Francisco, CA, March 6-11, 2016.

  96. Yu HE. The Inconvenient Truth about Near Patient Testing at the Doctor’s Office. Symposium: Chaired and presented. the Point-of-Care Diagnostic Symposium, Part of the 23rd International Molecular Medicine Tri-Conference, San Francisco, CA, March 10-11, 2016.

  97. Cohen S, Palmer M, Hossler E, Ferringer T. Pustular acrodermatitis enteropathica-like eruptions in the setting of total parenteral nutrition. Presentation. AAD Annual Meeting, Washington, DC, March 2016.

  98. Hossler E, Palmer M, Pride H. Highlights from the medical and pediatric literature. Presentation. AAD Annual Meeting, Washington, DC, March 2016.

  99. Hossler E. Pearls from the Posters. Moderator. AAD Annual Meeting, Washington, DC, March 2016.

  100. Kandukuri S, Liu H, Lin F. The diagnostic utility of CK7, maspin and MUC5AC in distinguishing gastric-foveolar type mucinous neoplasm of the pancreas from gastric contaminants on fine needle aspiration specimens. Platform Presentation. USCAP Annual Meeting, Seattle, WA, March 12-18, 2016.

  101. Liu H, Song QZ, Zhang Y, Chang Z, Lin F. Optimization of rapid immunohistochemical stains on frozen tissue sections. Poster. USCAP Annual Meeting, Seattle, WA, March 12-18, 2016.

  102. Yin H, Zhu S, Zelonis M, Snyder D, Kip NS, Chen ZE. Patchy high frequency of nonspecific abnormal signals (background noise): a common pitfall in interpretation of ALK FISH results. Abstract. USCAP Annual Meeting, Boston, March 12-18, 2016.

  103. Chen ZE, Bitting A, Kip NS, Lin F. Quality Assurance Aspects of implementing BRAFV600E Immunohistochemistry (IHC) Assay in Universal Lynch Syndrome Screening (ULS) for Colorectal Cancer (CRC): A Single Institution Experience. Abstract. United States and Canadian Academy of Pathology, March 12-16, 2016, Seattle, Washington.

  104. Liu H, Zhao SQ, Zhang Y, Zhang Z, LinF. Optimization of Rapid Immunohistochemical Stains on Frozen Tissue Sections. Poster presentation. United States and Canadian Academy of Pathology, March 12-16, 2016, Seattle, Washington.

  105. Kandikuri S, Prichard JW, Meschter SC. Relative Value of a Cytopathologist. Presentation. USCAP Annual Meeting, Seattle, WA, March 13-18, 2016.

  106. Strickler AG, Mahindra P, Votava H, Ratner D. Ductal Eccrine Adenocarcinoma of the Scalp. Poster. 19th Joint Meeting of the Internattional Society of Dermatopathology, Washington, DC, March 2016.

  107. Prichard JW, Meschter SC. Short Course 54: Practical Informatics Solutions for Anatomic Pathology Quality Management. Short Course. United States and Canadian Academy of Pathology , Seattle, Washington, March 12-18, 2016.

  108. Prichard JW. Valuing Quality Systems. Invited Lecture. Project Santa Fe Meeting, Santa Fe, New Mexico, March 22, 2016.

  109. Poler SM, Yu HE, Scholtis MP and Schieble TM. Comparison of Blood Glucose Determination from Earlobe Capillary Blood and Arterial Blood Specimens. Poster. Society for Technology in Anesthesiology Annual Meeting, Palm Beach, FL, January 6-9, 2016.

  110. Strickler AG. Skin Lesion Diagnosis and Monitoring. Invited Speaker. Frontline Skin Cancer Education Conference, Tallahassee, FL, December 5, 2015.

  111. Strickler, AG. Skin lesion diagnosis and monitoroing. Invited talk. Frontline Skin Cancer Education conference, Tallahassee, Florida , December 5, 2015.

  112. Ferringer T. Infestations, infections, and zoonoses. Visting Professor . Grand Rounds: Dept of Dermatology, Henry Ford Hospital, Detroit, MI, December 2015.

  113. Ferringer T. Immunohistochemistry of spindle cell lesions. Presentation. XXXVI Symposium for ISDP, New Delhi, India, November 2015.

  114. McGahan B, Clymer B, Kelly D, McComb R, Kazmi, SAJ, White M, Zhang Y. Assessment of vascularity in glioblastoma and its implications on patient outcomes. Abstract. 13th Annual AMA Research Symposium, Atlanta, GA, November 2015.

  115. West T, Turner G, Kazmi SAJ, et al. Temozolomide and Everolimus in the Treatment of Papillary Tumor of the Pineal Region . Abstract. Abstract presented at the Society of NeuroOncology annual meeting, San Antonio, TX, November 2015.

  116. Kip NS. Decoding >30 thousand patients for hereditary hemochromatoisis. Oral presentation. AMP 2015 Molecular Pathology Outreach Course, Austin, TX, November 4, 2015.

  117. Kip NS. Perspective of a IMG in Molecular Pathology. Oral presentation. AMP 2015 Science Educator Workshop, Austin, TX, November 4, 2015.

  118. Bulbin D, Meadows A, Kelsey S, Berger A, Kirchner HL, Harrison H, and Denio AE. Choosing subserologies more wisely: implementing anti-nuclear antibody (ana) reflex testing and education to reduce unnecessary costs in an integrated healthcare system. Poster/Abstract. ACR/ARHP Annual Meeting, San Francisco, CA, November 6-11, 2015.

  119. Harrison HH, Wolfe JR, Chowanes D, Weber SJ. Effect of noninvasive prenatal testing (NIPT) on prenatal aneuploidy screening uptake in a rural healthcare system. Poster/Abstract. CAP Annual Meeting, Nashville, TN, October 4-7, 2015.

  120. Tyler WB, Prickett K, Maroon M, Perlmutter A, Hossler E, Lin G. TRAPP, T-Cell Rich Angiomatoid Polypoid Pseudolymphoma of the Skin: Report of a Case. Poster. ASDP Annual Meeting, San Francisco, CA, October 2015.

  121. Liu H, Shi J, Xu V, Lin F. Impact of tissue decalcification on immunohistochemical detection of germ cell tumor markers. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

  122. Shi J, Xu V, Liu H, Lin F. Impact of tissue decalcification on immunohistochemical detection of lymphoid markers. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

  123. Lin F, Shi J , Xu V, Liu H. Impact of tissue decalcification on immunohistochemical detection of melanoma markers. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

  124. Hu L, Andrews C, Liu H, Dehner LP. Metastatic neoplasms to the thyroid gland. A report of 31 cases from a single medical center. Poster. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 4-7, 2015.

  125. Deng HB, Gao H, Zhang X, Lin F, Godyn J. E-Cadherin as a Potential Marker for Differential Diagnosis of Goblet Cell Carcinoid and Signet Ring Cell Carcinoma in Vermiform Appendix:. Poster 79. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 2015.

  126. Zhang K, Adler M, Schuerch C, Zhang X, Harrison H. Developing Best Practice Guidelines Improves Utilization and Decreases Expense of Immunophenotyping of Lymphoproliferative Disorders in Peripheral Blood. Poster 166. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 2015.

  127. Harrison H, Wolfe JR, Chowanes DJ, Weber SJ. Effect of Noninvasive Prenatal Testing on Prenatal Aneuploidy Screening Uptake in a Rural Health Care System. Poster 119. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 2105.

  128. Lin F. Impact of Tissue Decalcification on Immunohistochemical Detection of Lymphoid Markers. Poster 68. College of American Pathologists Annual Meeting 2015, Nashville, Tennessee, October 2015.

  129. Wilkerson ML. Preparing for the Future: Why you should be thinking automation now. Invited Panelist. 1. Roche SmartLab, Automation Panel Disussion, Washington, DC, October 1, 2015.

  130. Harrison HH, Weber S, Wolfe, Kip NS, Paglia. Maternal Serum Screening Uptake and Performance in a Rural Eastern US Healthcare System. Poster. ASCP Annual Meeting, Long Beach, CA, October 30-November 1, 2015.

  131. Rahm AK, Kip NS, Guha S, Fan A,, Kaspar HG, Williams JL, Gogoi R, Chen Z, Davis D, Williams MS. Coordinating laboratory and clinical data to incorporate endometrial tumor testing into the Universal Lynch Syndrome Screening program at Geisinger Health System. . National Society of Genetic Counselors Annual Education Conference, Pittsburgh, PA, October 20-24, 2015.

  132. Rahm AK, Kip NS, Guha S, Fan A,, Kaspar HG, Williams JL, Gogoi R, Chen Z, Davis D, Williams MS. Evaluation of Colorectal and Endometrial Cancer Screening Programs to Optimize Universal Lynch Syndrome Screening at Geisinger Health System. Poster. American Society of Human Genetics Annual Meeting, Baltimore, MD, October 6-10, 2015.

  133. Kip NS, Rahm S, Guha A, Fan A, Kaspar HG, Williams MS. Evaluation to Include Endometrial Carcinoma in Universal Lynch Syndrome Screening at Geisinger Health System. Abstract. ASCP Annual Meeting, Long Beach, CA, October 28-30, 2015.

  134. Haeberle MT, Rosamilia L, Lin G, Tyler WB. Multiple Myeloma Initially Presenting as Bullous Amyloidosis. Poster. ASDP Annual meeting, San Francisco, CA, October 7-11, 2015.

  135. Haeberle MT, Bhatt A, Kazmi SJ, Lin G. Multiple Myeloma Initially Presenting as Bullous Amyloidosis. Poster. ASDP Annual meeting, San Francisco, CA, October 7-11, 2015.

  136. Deng, HB. E-cadherin as a potential marker for differential diagnosis of goblet carcinoid and signet ring cell carcinoma in appendix. Abstract/poster. CAP Annual meeting, Nashville, TN, October 5, 2015.

  137. Lin F. Diagnostic Pathology Symposium. Co-Organizer. CAPA-Beijing , Beijing, China, October 16-18, 2015.

  138. Lin F. Select topics on pancreatobiliary pathology- IHC approach. Presented by Dr. H. Liu. CAPA-Beijing , Beijing, China, October 17, 2015.

  139. Ferringer T. Short course III at the border: mucocutaneous pathology. Course director. AAD Annual Meeting, San Francisco, CA, October 2015.

  140. Strickler AG, Bhatt AJ, Kazmi SJ, Lin G. Reticular Perineurioma. Poster. 52nd Annual Meeting of the American Society of Dermatopathology, Washington, DC, October 2015.

  141. Poler SM, Yu HE, Scholtis MP and Schieble TM. Comparison of Blood Glucose Determination from Earlobe Capillary Blood and Arterial Blood Specimens. Poster. American Society of Anesthesiologists, San Diego, CA, October 24-28, 2015.

  142. Kip NS. Clinical utility of NGS. Oral presentation. 25th Pathology Congress, Bursa, Turkey, October 2015.

  143. Lin F. Select topics on pancreatobiliary pathology- IHC approach. Lecture. China Cancer Hospital, Bejing, China, October 17, 2015.

  144. Schuerch C. Leading Just Culture Transformation, Pathologist Value: Contributing to Peer Review and Patient Safety in a Value-Based Health Care System. Invited lecture. College of American Pathologists Annual Meeting, Nashville, Tennessee, October 6, 2015.

  145. Haeberle MT, Rosamilia L, Lin G, Tyler WB. Multiple Myeloma Initially Presenting as Bullous Amyloidosis. Poster. American Society of Dermatopathology Annual Meeting, San Francisco, California, October 8-11, 2015.

  146. Chen Z. Quality management of IHC in diagnostic oncological pathology. Presentation. Pathology” Presented In The 1st China-Us Diagnostic Oncological Pathology Summit , Beijing, China, October 17, 2015.

  147. Qiu JJ, Grant ML, Uthup M, Luo X, Khan AI, Goldsmith BM. Validation Study for Nine Analytes in Non-Standard Body Fluids. Poster. American Society for Clinical Pathology Annual Meeting, Long Beach, California, October 2015.

  148. Qiu J, Grant M, Bains A. Diffuse Large B-Cell Lymphoma Transitioning to CD30 Positive Large Cell Non-Hodgkin Lymphoma in a Post Heart Transplant Patient. Oral presentation. Society of Hematopathology and European Association of Hematopathology worksho, Long Beach, California, October 2015.

  149. Luo X, Keller MA, James I, Liu S, Oros ML, Iftikhar A, Dobey TX, Czulewicz, Nance SJ, Li Y. Strategies to Identify Candidates for Genotyping of D Variants. Poster. American Association of Blood Banks Annual Meeting, Anaheim, California, October 2015.

  150. Mamone L, Grant M, Mukherjee A. Fatal Strongyloides stercoralis Infection in Urban America: Two Autopsy Cases. Poster. College of American Pathologists Annual Meeting, Nashville, Tennessee, September 2015.

  151. Bulbin DH, Spiker A, Marks V, Tyler WB, Harrington T, Denio AE. Fishing for a Diagnosis, the Case of Polyarteritis Nodosa (PAN) that was Almost Never Caught . Poster. Pennsylvania Rheumatology Society Meeting , Hershey, PA, September 26, 2015.

  152. Wehler A. Patient Blood Management Efforts Synchronized Across a Health System. Poster. Society for the Advancement of Patient Blood Management annual meeting, Orlando, FL, September 24-26, 2016.

  153. Lin F. Diagnostic Pathology Course. Course Director. Chinese American Pathologists Association (CAPA), Flushing, NY, August 2015.

  154. Lin F. Undifferentiated carcinoma: using IHC approach. Lecture. The First Chinese American Pathologists Association (CAPA) Diagnostic Pathology Course, Flushing, NY, August 2015.

  155. Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Boston University, Boston, MA, August 2015.

  156. Ferringer T. Leading innovation when your environment is changing . Co-director. Summer AAD Meeting, New York, NY, August 2015.

  157. Ferringer T. Tips from your dermatopathologist: help me help you. Co-director. Summer AAD Meeting, New York, NY, August 2015.

  158. Lin F. The First Chinese American Pathologists Association (CAPA) . Diagnostic Pathology Course. CAPA, Flushing, New York, August 22-24, 2015.

  159. Lin F. Undifferentiated carcinoma: using IHC approach. Lecture. The First CAPA Diagnostic Pathology Course, Flushing, New York, August 22, 2015.

  160. Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Boston University, Boston, Massachusetts, August 28, 2015.

  161. Chen Z. New IHC markers useful in diagnosis of colorectal cancer. Speaker. 1st CAPA Diagnostic Pathology Course, Flushing, New York, August 22, 2015.

  162. Sneidman MR, Yu HE. Performance comparison of Six Different Rapid Screening Drug Test Cards / Cups. Poster. American Association of Clinical Chemistry Annual Meeting, Atlanta, GA, July 26-30, 2015.

  163. Lo SY, Gordon C, Sadilkova D, Jack RM, Dickerson JA. Serum methylmalonic acid quantitation by LC-MS/MS for monitoring methylmalonic acidemia. Poster. American Association of Clinical Chemistry Annual Meeting, Atlanta, Georgia, July 2015.

  164. Yu HE. Selecting Automation / Instrumentation for Clinical Laboratory – it’s more than just finding the right technology. Presentation. American Association of Clinical Chemistry Annual Meeting, Atlanta, GA, July 26-30, 2015.

  165. Jones JB, Quinton LE, Vendely BG, and Harrison HH. Efficiency of online cap proficiency testing . Poster/Abstract. AACC Annual Meeting, Atlanta, GA, July 26-30, 2015.

  166. Wilkerson ML. 5 Forward-Thinking Principles for Choosing an IVD Vendor-Partner. Invited Speaker. Roche L2 LabLeaders Summit, Philadelphia, PA, June 24, 2015.

  167. Yu HE. Decision Support for Urine Drug Testing for Pain Management. Presentation. Canadian Laboratory Medicine Congress, Montreal, Canada, June 20-24, 2015.

  168. Yu HE. Selecting Automation / Instrumentation for Clinical Laboratory – it’s more than just finding the right technology. Presentation. Canadian Laboratory Medicine Congress, Montreal, Canada, June 20-24, 2015.

  169. Ferringer T. Hemagophagocytic syndromes. Speaker. World Congress of Dermatology, Vancouver, British Columbia, Canada, June 2015.

  170. Ferringer T. FISHing for a diagnosis: cytogenetic and molecular analysis of relevance to dermatopathologists . Speaker. Scientific Symposium: Critical Issues in Cutaneous Pathology: Critical New Information for Your Practice, Williamsburg, VA, June 2015.

  171. Ferringer T. Tag-alongs and their associated diseases. Speaker. Scientific Symposium: Critical Issues in Cutaneous Pathology: Critical New Information for Your Practice, Williamsburg, VA, June 2015.

  172. Ferringer T. Infectious dermatopathology. Speaker. Scientific Symposium: Critical Issues in Cutaneous Pathology: Critical New Information for Your Practice, Williamsburg, VA, June 2015.

  173. Ferringer T. Cutaneous reactions to new classes of drugs. Speaker. Scientific Symposium: Critical Issues in Cutaneous Pathology: Critical New Information for Your Practice, Williamsburg, VA, June 2015.

  174. Ferringer T. Great cases from Geisinger Health System. Speaker. Scientific Symposium: Critical Issues in Cutaneous Pathology: Critical New Information for Your Practice, Williamsburg, VA, June 2015.

  175. Mamone L, Grant M, Geier S, James I, Luo X, Patel V, Liu Z, Nance S, Borge P, Li Y. Case: RhD Alloimmunization after Transfusion of One Unit of Apheresis Platelets. Poster. International Society of Blood Transfusion annual meeting,, London, England, June 2015.

  176. Kim V, Cornwell WD, Oros M, Durra, H, Criner GJ, and Rogers, TJ. Plasma Chemokine Signature Correlates with Lung Goblet Cell Hyperplasia in Smokers with and without COPD. Poster. American Thoracic Society annual meeting, Denver, Colorado, May 2015.

  177. Kim V, Cornwell WD, Criner GJ, Oros M, Durra H, and Rogers TJ. Induction of Epidermal Growth Factor and Interleukins 1, 8, and 9 Expression in the Lungs in Chronic Bronchitis and COPD. Poster. American Thoracic Society annual meeting, Denver, Colorado, May 2015.

  178. Hossain NM, Liu S, Grant M, Moolten DN, Li Y, Essex D. A Case of Promptly Diagnosed Post-Partum Complement-mediated Thrombotic Microangiopathy after Brief Plasma Exchange Treatment Successfully Treated with Eculizumab. Poster. American Society for Apheresis Annual Meeting, San Antonio, Texas, May 2015.

  179. Grant ML, Moolten DN, Hossain N, Wang J, Patel V, Essex D, Bromberg M, Czulewicz A, Li Y. Complete Heart Block in Thrombotic Microangiopathy Syndrome Improved after Plasma Exchange. Poster. American Society for Apheresis Annual Meeting, San Antonio, Texas, May 2015.

  180. Lo SY, Baird GS, Hoofnagle AN, Greene DN.. THC use and marijuana legalization do not influence chronic opioid therapy. Platform presentation. 50th Annual Academy of Clinical Laboratory Physicians and Scientists, Minneapolis, Minnesota, May 2015.

  181. Hernandez Dr, Newton DW, Ledoboer NA, Buchan BW, Solenberger AC, Young C, Connoly J, Martinez RM, Wolk DM. Multi-center Evaluation of MRSASelect II Chromogenic Agar for Identification of Methicillin-Resistant Staphylococcus aureus in Wound and Nasal Sample. Abstract C568. American Society for Microbiology General Meeting, New Orleans, LA, May 18-21, 2015.

  182. Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Temple University Hospital, Philadelphia, Pennsylvalnia, May 22, 2015.

  183. Lin F. IHC Quality Management. Pathology Grand Rounds. Temple University Hospital, Philadelphia, Pennsylvalnia, May 22, 2015.

  184. Martinez RM, Scicchitano LM, Tomashefski FJ, Heiter BJ, Ney YA, Wolk, DM . Evaluation of the Focus Simplexa Group A Strep analyte-specific reagent (GAS-ASR) used with the Janus pipetting system for the detection of Group A streptococcus from throat swabs. Poster Abstract. American Society for Microbiology, New Orleans, LA, May 30 – June 2, 2015.

  185. Lin F. Undifferentiated carcinoma: using IHC approach; IHC quality management. Grand Rounds. Temple University Hospital, Philadelphia, PA, May 2015.

  186. Lin F. Undifferentiated carcinoma: using IHC approach. Grand Rounds. Methodist Hospital, Houston, TX, April 2015.

  187. Martinez RM, Scicchitano LM, Tomashefski FJ, Wolk DM. Performance of two newly updated direct from sample methods for detection of influenza A/B and respiratory syncytial virus. Poster Abstract. Clinical Virology Symposium (CVS), Daytona Beach, FL, April 26-29, 2015.

  188. Ferringer T. Cutaneous infections in North America part I. Lecture. Dermpedia course: Common Areas of Interest for Dermatopathologists and Surgical Pathlogists, Scottsdale, AZ, April 2015.

  189. Ferringer T. Cutaneous reactions to biologics and new classes of drugs. Lecture. Dermpedia course: Common Areas of Interest for Dermatopathologists and Surgical Pathlogists, Scottsdale, AZ, April 2015.

  190. Ferringer T. Infections from suburban North America part II. Lecture. Dermpedia course: Common Areas of Interest for Dermatopathologists and Surgical Pathlogists, Scottsdale, AZ, April 2015.

  191. Ferringer T. Infestations. Lecture. Dermpedia course: Common Areas of Interest for Dermatopathologists and Surgical Pathlogists, Scottsdale, AZ, April 2015.

  192. Ferringer T. Teaching Case. Lecture. Dermpedia course: Common Areas of Interest for Dermatopathologists and Surgical Pathlogists, Scottsdale, AZ, April 2015.

  193. Ferringer T. Update on IHC in DP. Lecture. Dermpedia course: Common Areas of Interest for Dermatopathologists and Surgical Pathlogists, Scottsdale, AZ, April 2015.

  194. Nicolli EA, Ghosh A, Haft S, Frank R, Saunders J, Cohen N, Mirza N. IL-1 receptor antagonist inhibits early granulation formation. Platform presentation. Combined Otolaryngology Spring Meetings- 95th Annual meeting, American Broncho-Esophagological Association, Boston, Massachusetts, April 2015.

  195. Schuerch C. What Else Should Laboratories Be Doing in an ACO. Invited Lecture. Pennsylvania Association of Pathologists Annual Meeting, Harrisburg, Pennsylvania, April 11, 2015.

  196. Lin F. Undifferentiated carcinoma: using IHC approach. Pathology Grand Rounds. Methodist Hospital, Houston, Texas, April 7, 2015.

  197. Wilkinson L, Liu H, Meschter S, Aaron K, Lin F. Effect of Needle Rinse Solution on Cellularity of Cellblock Preparations in Fine Needle Aspiration Biopsies. Poster Presentation. United States and Canadian Academy of Pathology, Boston, Massachusetts, March 2015.

  198. Levinson K, Frank R, Shroff SG. Evaluation of Intraoperative Frozen Section Discrepancies for. Abstract. United States and, Boston, Massachusetts, March 2015.

  199. Yin H, Zhu S, Zelonis M, Snyder D, Kip NS, Chen ZM. Insufficient formalin fixation can negatively affect detection of ALK rearrangement in lung cancer by fluorescence in situ hybridization (FISH). Presentation. United States &Canadian Academy of Pathology, Boston, Massachusetts, March 17-21, 2015.

  200. Davison JM, Prichard JW, Campbell B, Repa K, Reese LM, Nguyen XM, Foxwell T, Li J, Diehl DL, Barley M, Falk GW, Jhala NC, DeMarshall M, Bergman J, Duits LC, Jobe BA, Zaidi A, Zhang Y, Critchley-Thorne RJ. Quantitative Multiplexed Biomarker and Morphology Analysis To Aid Diagnosis of Dysplasia in Barrett's Esophagus. Poster. USCAP Annual Meeting, Boston, MA, March 21-27, 2015.

  201. Yin H, Zhu S, Zelonis M,. Insufficient formalin fixation can negatively affect detection of ALK rearrangement in lung cancer by fluorescence in situ hybridization (FISH). Poster. USCAP Annual Meeting, Boston, MA, March 21-27, 2015.

  202. Prichard JW, Meschter SC. Short Course 54: Practical Informatics Solutions for Anatomic Pathology Quality Management. Short Course. United States and Canadian Academy of Pathology , Boston, Massachusetts, March 21-27, 2015.

  203. Ferringer T. Adverse cutaneous drug reactions to targeted anti-inflammatory therapies in new patterns of cutaneous adverse drug reactions. Lecture. ISDP Joint Meeting, San Francisco, CA, March 2015.

  204. Ferringer T. Dermatology Teachers Exchange. Director. Dermatology Teachers Exchange, San Francisco, CA, March 2015.

  205. Ferringer T. Leading innovation when your environment is changing. Co-director. AAD Annual Meeting, San Francisco, CA, March 2015.

  206. Ferringer T. Metabolic disorders (in Essential Dermatopathology course). Lecture. AAD Annual Meeting, San Francisco, CA, March 2015.

  207. Ferringer T. Basic self-assessment of dermatopathology. Lecture. AAD Annual Meeting, San Francisco, CA, March 2015.

  208. Ferringer T. Barnyard zoonoses (in Infectious Disease course). Lecture. AAD Annual Meeting, San Francisco, CA, March 2015.

  209. Ferringer T. What’s new in adnexal tumors (in what’s new in DP). Lecture. AAD Annual Meeting, San Francisco, CA, March 2015.

  210. Kip NS, He R, Viswanatha DS, Mai M, Johnson SH, Dogan A, Vasmatzis G, Feldman A. T-Cell Receptor Gene Rearrangements in Anaplastic Large Cell Lymphoma: Associations With Pathology and Genetics. Poster. USCAP Annual meeting, Boston, MA, March 27-21, 2015.

  211. Liu H, Lin F. Immunohistochemical expression of NKX2.2 in 1228 human tumors. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

  212. Liu H, Lin F. Immunohistochemical expression of NKX3.1 in human tumors. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

  213. Lin F, Shi J, Chen Z, Liu H. Impact of tissue decalcification on immunohistochemical detection of select markers for carcinoma of unknown origin. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

  214. Shi J, Xu V, Liu H, Lin F. Impact of tissue decalcification on immunohistochemical detection of breast carcinoma markers. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

  215. Chen Z, Yin H, Li J, Zhu S, Lin F. Improving HER2 assessment in gastroesophageal junction (GEJ) and gastric adenocarcinoma (GADC): lessons from concurrent immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) study of 117 specimens. Abstract/Presentation. USCAP Annual Meeting, Boston, MA, March 2015.

  216. Liu H, Shi J, Xu V, Lin F. Impact of tissue decalcification on immunohistochemical detection of select sarcoma markers. Poster. USCAP Annual Meeting, Boston, MA, March 21-27, 2015.

  217. Lin F, Shi J , Xu V, Liu H. Impact of Tissue Decalcification on Immunohistochemical Detection of Melanoma Markers. Poster Presentation. The United States and Canadian Academy of Pathology, Boston, Massachusetts, March 21-27, 2015.

  218. Hossler E, Pride H. Highlights in medical dermatology 2014. Presentation. AAD Annual Meeting, San Francisco, CA, March 2015.

  219. Lin F. Geisinger Pathology Lecture Series. Lecture organizer. Geisinger Pathology Lecture Series, Geisinger Medical Center, Danville PA, Throughout 205.

  220. Stark A. Prichard JW, Chitale D, Pepe, MS, Engstrom P. High quality population-based cohort of benign breast conditions (BBC): A foundational frame-work for breast cancer (BC) risk estimation. Presentation. 2014 San Antonio Breast Cancer Symposium, San Antonio, TX, December 9-13, 2014.

  221. Jones JB. Understanding the Lab’s Role in Information Management for Personalized Dx and Accountable Care. Virtual Webinar. American Association for Clinical Chemistry Personalized Medicine , Point-of-Care Net , November 2014.

  222. Martinez RM, Scicchitano LM, Tomashefski FJ, Wolk DM. Evaluation of the Cepheid Xpert Flu/RSV assay for the detection of influenza A/B and RSV. Poster Abstract. Association for Molecular Pathology Annual Meeting, National Harbor, MD, November 13-15, 2014.

  223. Chandler WM. Agminated Cutaneous Leiomyosarcomas? A Case of Reed's Syndrome Argues for the Atypical Intradermal Smooth Muscle Neoplasm Designation. Poster. American Society of Dermatopathology (ASDP) 51st Annual Meeting, Chicago, IL, November 6-9, 2014.

  224. Lin F, Shahab A, Liu H. Diagnostic utility of cell blocks with immunostains in Papanicolaou tests (liquid-based preparation). Presentation. ASC Annual Meeting, Dallas, TX, November 1-17, 2014.

  225. Turner SG, Kazmi SAJ, Fourgas E, et al. Malignant Glioma with Primitive Neuroectodermal Components: Clinical and Pathologic Features of Five Cases . Abstract. Society of NeuroOncology Annual Meeting, Miami, FL, November 2014.

  226. Chandler W, Kazmi S, Lin G. Agminated Cutaneous Leiomyosarcoma? A Case of Reed’s Syndrome Argues for the Atypical Intradermal Smooth Muscle Neoplasm Designaton. Poster. American Society of Dermatopathology Annual Meeting, Chicago, Illinois, November 6-9, 2014.

  227. Shockman S, Cohen S, Lin G, Ferringer T. Diffuse Dermal Angiomatosis Incited by Trauma. Poster. American Society of Dermatopathology Annual Meeting, Chicago, Illinois, November 6-9, 2014.

  228. Oros ML, Geier S, Lin J, Meny G, Hsu SH, Vassallo RR, Li Y. Diagnosis and Management of Platelet Refractoriness in a Bleeding Patient Following Massive Platelet Transfusion. Poster. American Association of Blood Banks Annual Meeting, Philadelphia, Pennsylvania, October 2014.

  229. Martinez RM. The wonderful world of clinical microbiology. Presentation. Bard College, Annandale-On-Hudson, NY , October 9, 2014.

  230. Jones JB. Process Improvement for Critical and Point of Care Testing (CPOCT): A “Lean” Perspective. Webinar. New Jersey POCT Coordinators , Point-of-Care Net , October 2014.

  231. Olson J, Pauli J, Erdman P, George M . Clinical outcomes of gravid patients with non-specific antibodies identified by solid phase testing during routine screening. Presentation. American Association of Blood Banks, Tampa, Florida, October 25-28, 2014.

  232. Olson J, Cheng R, Castellani W. Design and Implementation of a Real Time Dashboard for a clinical laboratory pneumatic tube system. Presentation. Annual Meeting of the American Society of Clinical Pathology, Tampa, Florida, October 8-10, 2014.

  233. Michelotti B, Olson J, Brooke S, Johnson TS . Can Platelet-rich Plasma Impact the Formation of Flexor Tendon Adhesions?. Presentation. Northeastern Society of Plastic Surgeons Annual Meeting, Providence, Rhode Island, October 10-14, 2014.

  234. Maio CL, Li JH, Mowery AD, Khara H, Inverso N, Yuasa K. A case of drug-induced liver injury by the new diabetes drug Canagliflozin. Presentation. American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA, October 17-22, 2014.

  235. Rezk AN, Gunnerson CA, Komar M, Zhang K . Whipple’s didease: a Fetal Disease that is often Missed without Gastrointestinal Syndrome. Poster. American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA, October 17-24, 2014.

  236. Reyes MC, Tsang P . CD8 cytotoxic peripheral T-cell lymphoma, not otherwise specified, in a young child. Case report and literature review. College of American Pathologists Annual Meeting, Chicago, Illinois, September 2014.

  237. Prichard JW. Practical informatics solutions for AP quality management. Presentation. Quality Assurance and the Impact on Patient Diagnosis Workshop, Waltham, MA, September 16-17, 2014.

  238. Wehler A. Effect of Education and Performance Feedback on Red Blood Cell Transfusion Practice. Poster. Society for the Advancement of Blood Management Annual Meeting, Houston, Texas, September 11-13, 2014.

  239. Lin F, Shi J, Chen ZM, Liu H. Immunohistochemical evaluation of c-Myc expression in carcinomas from various organs. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

  240. Liu H, Okponobi S, Shi J, Lin F. Identification of a useful immunostaining panel in the distinction between esophageal and pancreatic adenocarcinomas. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

  241. Liu H, Lin F. Re-evaluation of expression of immunomarkers in lung adenocarcinomas. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

  242. Liu H, Lin F. Immunohistochemical evaluation of Ber-EP4, MOC-31, TAG-72, and CEA in various carcinomas. Presentation. CAP Annual Meeting, Chicago, IL, September 7-10, 2014.

  243. Kip NS. Translational research opportunities at GHS. Oral presentation. Turkish Research Council, Instanbul, Turkey, September 2014.

  244. Littelejohn A, Oros ML, Li KY, Kwak D, Balasubramanian E, Li Y. Evaluation of Blood Transfusion Practices in Hip Arthroplasty Patients. Poster. Temple University Undergraduate Research Program Symposiu, Philadelphia, Pennsylvania, September 2014.

  245. Ferringer T. FISHing for a diagnosis. What’s Hot in Dermatopathology . Summer AAD Meeting, Chicago, IL, August 2014.

  246. Yu HE. Decision Support for Urine Drug Testing for Pain Management. Presentation. American Association of Clinical Chemistry Annual Meeting, Chicago, IL, July 27-31, 2014.

  247. Sneidman MR and Yu HE. Comparison of Roche Methadone Screening Assay with DRI Methadone Metabolite (EDDP) Screening Assay. Presentation. American Association of Clinical Chemistry Annual Meeting, Chicago, IL, July 27-31, 2014.

  248. Jones JB, Harrison H, Sargent DD, Labarbera J, Sneidman M. Seasonal Variation of Vitamin D Deficiency in a Large Rural Health System: Effect of Assay Change on Deficiency Prevalence. Poster A-192. American Association for Clinical Chemistry Annual Meeting , Chicago, IL, July 2014.

  249. Jones JB, Heirema E. New Instrument Interface Standard to Enable Improved Interoperability with Integrated Information. Poster. American Association for Clinical Chemistry Annual Meeting, , Chicago, IL, July 2014.

  250. Jones JB. Integrating Big Data Across the Health Enterprise: the Pathway to Improved Clinical Outcomes. Sympostium. American Association for Clinical Chemistry Annual Meeting, , Chicago, IL, July 2014.

  251. Yu HE. Decision Support for Urine Drug Testing for Pain Management. Presentation. American Association of Clinical Chemistry Annual Meeting, Chicago, IL, July 27-31, 2014.

  252. Wilkerson M. Man vs. Machine: New Method Validation. Course Director and Speaker. Geisinger Medical Laboratories, Wilkes-Barre and Danville, Pennsylvania, June-September 2014.

  253. Zhang X. Expression of three new immunohistochemical markers in different small B-cell lymphomas. Poster presentation PP-LYMP-007. XVII meeting of the European association for Haematopathology, Istanbul, Turkey, May 2014.

  254. Kim V, Cornwell W, Oros ML, Criner GJ, Rogers TJ. Systemic and Lung Cytokines and Their Relationship with Respiratory Symptoms in COPD. Poster. American Thoracic Society Annual Meeting, San Diego, California, May 2014.

  255. Kim V, Oros ML, Rogers TJ, Criner GJ, and Durra H. Chronic Bronchitis Have More Goblet Cells and Greater Respiratory Symptoms in Smokers and COPD Subjects. Poster. American Thoracic Society Annual Meeting, San Diego, California, May 2014.

  256. Liu S, Hossain N, Oros ML, Qiu J, Zibelman M, Lin J, Manucha V, Moolten D, Essex D, Li Y. Case Report: A Postoperative Thrombotic Thrombocytopenic Purpura Following Small Bowel Resection Quickly Resolved by Timely Plasma Exchange. Poster. American Society for Apheresis Annual Meeting, San Francisco, California, May 2014.

  257. Hernandez DR, Deitrick-Beltz KA, Martinez RM, Wolk DM. Controlled clinical laboratory comparison of QuickFISH and FilmArray BCID panel for identification of microorganisms in new BacT/ALERT FA blood culture bottle. Poster Abstract. American Society for Microbiology (ASM) General Meeting, Boston, MA, May 17-20, 2014.

  258. Martinez RM. How to insure the best specimen is collected for optimal microbiology results. Presentation. CE Presentation, Danville, PA, May 2014.

  259. Ferringer T. Infectious Disease with Cutaneous Histopathology. Guest Speaker. McKee/Pratt-Thomas Symposium , Kiawah, SC, May 2014.

  260. Pineda-Bonilla JJ, Johal Amitpal, Maio Chuan, Khara HS, Chen ZM, Li J, Prichard JW, Diehl DL. EUS-guided liver biopsy provides diagnostic samples with quantitative yields superior to percutaneous or transjugular routes. Presentation. American Gastroenterological Association Digestive Disease Week, Chicago, IL, May 3-6, 2014.

  261. Pineda-Bonilla, JJ, Kim, A, Johal A, Miao CL, Khara HS, Li JH, Prichard, JW, Chen ZM, Diehl DL . Assessment of hepatic steatosis by computerized image analysis using whole slide scanning technology. Presentation. American Gastroenterological Association Digestive Disease Week, Chicago, IL, May 3-6, 2014.

  262. Ferringer T. Immunohistochemistry in Cutaneous Lesions. Guest Speaker. McKee/Pratt-Thomas Symposium , Kiawah, SC, May 2014.

  263. Ferringer T. Grand Rounds. Visiting Professor. Department of Dermatology, Virginia Commonwealth University, April 2014.

  264. Mi W, Diehl Dl, Shi J, Blansfield J, Hunsinger MA, Yang W, Lin F. S100P is a potential biomarker in distinguishing mucinous from non-mucinous pancreatic cysts and predicting invasive adenocarcinoma. Presentation. AACR Annual Meeting, San Diego, CA, April 5-9, 2014.

  265. Martinez RM, Scicchatano LM, Tomashefski FJ, Leberfinger MA, McElhinny AO Wolk DM . Real-time monitoring of respiratory illness during flu season using Altosoft. Poster Abstract. Clinical Virology Symposium (CVS), Daytona Beach, FL, April 26 - 28, 2014.

  266. Stanhope TJ, Kip NS, Chien JR, Brost BC. Expression of Protease HtrA1 is Increased at the Site of Ectopic Pregnancy. Poster. The American College of Obstetricians and Gynecologists Annual Meeting, Chicago, IL, April 26-30, 2014.

  267. Shahab A, Liu H, Lin F. Uroplakin II is a useful immunomarker for identification of urothelial carcinomas. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

  268. Lin F, Shi J, Liu H. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of napsin A expression in lung adenocarcinomas. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

  269. Liu H, Shi J, Prichard J, Lin F. TROP-2 is a potential novel immunomarker for identification of papillary thyroid carcinomas. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

  270. Chen ZM, Liu H, Lin F. Loss of PAX2 nuclear expression: a useful diagnostic feature for in situ and invasive endocervical adenocarcinoma. Presentation. USCAP Annual Meeting, San Diego, CA, March 1-7, 2014.

  271. Ferringer T. Barnyard Zoonoses. Infectious Disease Course. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  272. Ferringer T. What’s New in Immunohistochemistry . What’s New in DP. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  273. Ferringer T. Basic Self-Assessment of Dermatopathology. Dermatopathology Course. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  274. Ferringer T. Metabolic Disorders . Basic Dermatopathology Course. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  275. Ferringer T. Dermatology Teachers Exchange. Director. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  276. Ferringer T. Adnexal tumors. Practical Approaches to Difficult Lesions. International Society of Dermatopathology 17th Joint Meeting, Denver, CO, March 2014.

  277. Hossler E. Tinea infections: diagnostic and therapeutic considerations. Presentation. Annual Family Practice Review, Lancaster, PA, March 25 and October 7, 2014.

  278. Taglia L, Hossler E. A case of localized facial dermatitis herpetiformis. Presentation. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  279. Sivendran M, Hossler E, Ferringer T.. Herpes simplex virus induced necrotizing granuloma formation. Presentation. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  280. Hossler E, Pride H. Highlights in medical dermatology 2013. Presentation. American Academy of Dermatology Annual Meeting, Denver, CO, March 2014.

  281. Prichard JW, Meschter SC. Short Course 54: Practical Informatics Solutions for Anatomic Pathology Quality Management. Short Course. United States and Canadian Academy of Pathology , San Diego, California, March 1-7, 2014.

  282. Frank R, Greene MI, Lal P. onoclonal Antibody F77 Is Prevalent in Non-Prostatic Tumors. Abstract. United States and Canadian Academy of Pathology, San Diego, California, March 2014.

  283. Yu HE. Establish Partnership between Laboratory and Healthcare Providers to Improve Clinical Utility of Point-of-Care Testing. Presentation. Third Annual Point-of-Care Diagnostic Symposium, Part of the 21st Annual Molecular Medicine Tri-Conference, San Francisco, CA, February 13-14, 2014 .

  284. Yu HE. Panel Discussion: Point-of-Care Implementation: Commercial, Health System, and Pharmacy Perspectives. Panel Discussion. Third Annual Point-of-Care Diagnostic Symposium, Part of the 21st Annual Molecular Medicine Tri-Conference, San Francisco, CA, February 13-14, 2014 .

  285. Schuerch C. The Lab’s Role in Improving the Healthcare Value Proposition: A Geisinger Case Study. Grand Rounds. Temple University School of Medicine Department of Pathology and Laboratory Medicine Grand Rounds, Philadelphia, PA, January 2014.

  286. Wehler A. KRAS & BRAF Mutation Status in Correlation with MMR Protein Status by IHC in Colorectal Adenocarcinomas Diagnosed at Geisinger Health System. Presentation. Geisinger faculty research open house, Danville, PA, January 2014.

  287. Kip S, Prichard J, Chen E, Li J, Harrison H, Wehler A, Paynton B, Urban B, Knock B, Schicchitano, Rodino S. KRAS and BRAF Mutation Status in Correlation with MMR Protein Status in Colorectal Cancer Cases Diagnosed at Geisinger Health System. Poster 27. Geisinger Faculty Research Open House, Danville, PA, January 2014.

  288. Schuerch C . The Lab’s Role in Improving the Healthcare Value Proposition: A Geisinger Case Study. Grand Rounds. Temple University School of Medicine Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, January 24, 2014.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2016 Geisinger Health System.   All rights reserved.